Skip to content
healthcare.dev
Get a free key

NEMLUVIO

NDC 0299-6220, nemolizumab-ilto, injection, powder, lyophilized, for solution, from Galderma Laboratories, L.P..

Product NDC
0299-6220
Status
Listed
Labeler
Galderma Laboratories, L.P.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761390
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0299-6220 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEMOLIZUMAB30 mg/100mg

Pharmacologic classes

Interleukin-31 Receptor alpha Antagonist [EPC]; Interleukin-31 Receptor alpha Antagonists [MoA]

Package NDCNDC-11Package
0299-6220-10002996220101 SYRINGE, GLASS in 1 CARTON (0299-6220-10) / 30 mg in 1 SYRINGE, GLASS
0299-6220-15002996220151 SYRINGE in 1 CARTON (0299-6220-15) / 30 mg in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e9229ef1-ac60-4c24-afb6-009d3c781687

Use it

Look up 0299-6220 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0299-6220 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0299-6220. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.